Thomas J. Schuetz
CHIEF EXECUTIVE OFFICER at Compass Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Compass Therapeutics Inc., 3 years.
Compass Therapeutics Inc.
Director · PRESIDENT
Chief executive roles
Compass Therapeutics Inc.
· CHIEF EXECUTIVE OFFICER
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 8, 2024 | Compass Therapeutics Inc. | Shares withheld for tax | −44,782 | $1.45 | $64,934 |
| Jan 9, 2024 | Compass Therapeutics Inc. | Grant or award | +637,500 | $1.93 | $1,230,375 |
| Nov 17, 2023 | Compass Therapeutics Inc. | Shares withheld for tax | −44,025 | $1.50 | $66,038 |
| Mar 10, 2023 | Compass Therapeutics Inc. | Open-market purchase | +10,000 | $3.37 | $33,700 |
| Feb 27, 2023 | Compass Therapeutics Inc. | Open-market purchase | +20,000 | $3.98 | $79,600 |
| Feb 15, 2023 | Compass Therapeutics Inc. | Open-market purchase | +20,000 | $3.86 | $77,200 |
| Feb 8, 2023 | Compass Therapeutics Inc. | Grant or award | +500,000 | — | — |
| Jan 31, 2023 | Compass Therapeutics Inc. | Open-market purchase | +20,000 | $4.05 | $81,000 |
| Jan 24, 2023 | Compass Therapeutics Inc. | Open-market purchase | +20,000 | $4.19 | $83,800 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.